{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:14:13Z","timestamp":1788952453250,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154514","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:12:32Z","timestamp":1787922752000},"page":"154514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Non-coding RNAs in diabetic cardiomyopathy: Mechanistic insights, diagnostic and prognostic potential, and therapeutic perspectives"],"prefix":"10.1016","volume":"834","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6752-1326","authenticated-orcid":false,"given":"Farhan","family":"Ullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7212-7201","authenticated-orcid":false,"given":"Hamad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154514_bib1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13062-022-00346-6","article-title":"LncRNA Airn alleviates diabetic cardiac fibrosis by inhibiting activation of cardiac fibroblasts via a m6A-IMP2-p53 axis","volume":"17","author":"Peng","year":"2022","journal-title":"Biol. Direct"},{"key":"10.1016\/j.bbrc.2026.154514_bib2","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.18632\/aging.204256","article-title":"LncRNA H19 inhibits ER stress induced apoptosis and improves diabetic cardiomyopathy by regulating PI3K\/AKT\/mTOR axis","volume":"14","author":"Wang","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbrc.2026.154514_bib3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.omtn.2023.04.025","article-title":"LncRNA ZNF593-AS alleviates diabetic cardiomyopathy via suppressing IRF3 signaling pathway","volume":"32","author":"Xie","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbrc.2026.154514_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12933-021-01245-2","article-title":"MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics","volume":"20","author":"Jakubik","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbrc.2026.154514_bib5","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCRESAHA.120.318437","article-title":"LncRNA ZNF593-AS alleviates contractile dysfunction in dilated cardiomyopathy","volume":"128","author":"Fan","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2026.154514_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00109-023-02305-8","article-title":"Non-coding RNAs regulating mitochondrial function in cardiovascular diseases","volume":"101","author":"Ao","year":"2023","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.bbrc.2026.154514_bib7","article-title":"Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease","volume":"13","author":"Li","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154514_bib8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/s41419-018-1029-4","article-title":"Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.154514_bib9","article-title":"Long Non-coding RNA: a key regulator in the pathogenesis of diabetic cardiomyopathy","volume":"8","author":"Guo","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bbrc.2026.154514_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/15476286.2015.1020271","article-title":"Regulation of circRNA biogenesis","volume":"12","author":"Chen","year":"2015","journal-title":"RNA Biol."},{"key":"10.1016\/j.bbrc.2026.154514_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12933-024-02252-9","article-title":"Roles of non-coding RNA in diabetic cardiomyopathy","volume":"23","author":"Yao","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbrc.2026.154514_bib12","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2337\/db11-0952","article-title":"MicroRNA dysregulation in diabetic ischemic heart failure patients","volume":"61","author":"Greco","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2026.154514_bib13","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/MCB.01222-08","article-title":"MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes","volume":"29","author":"Ikeda","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.154514_bib14","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1172\/JCI36154","article-title":"MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice","volume":"119","author":"Callis","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.154514_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCRESAHA.116.304707","article-title":"MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1\/AMPK pathway","volume":"116","author":"Kuwabara","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2026.154514_bib16","article-title":"miR-340-5p mediates cardiomyocyte oxidative stress in diabetes-induced cardiac dysfunction by targeting Mcl-1","volume":"2022","author":"Zhu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbrc.2026.154514_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s11658-022-00379-9","article-title":"Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy","volume":"27","author":"Yu","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bbrc.2026.154514_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12318","article-title":"Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1","volume":"36","author":"Tang","year":"2018","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.bbrc.2026.154514_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.carpath.2015.06.003","article-title":"Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice","volume":"24","author":"Yu","year":"2015","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.bbrc.2026.154514_bib20","article-title":"The microRNA in ventricular remodeling: the miR-30 family","volume":"39","author":"Zhang","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbrc.2026.154514_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/4050116d-8daa-4b5a-99e9-34cdd13f6a26","article-title":"miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway","volume":"6","author":"Li","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbrc.2026.154514_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.430","article-title":"MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.154514_bib23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bbrc.2016.06.051","article-title":"miR-483-3p regulates hyperglycaemia-induced cardiomyocyte apoptosis in transgenic mice","volume":"477","author":"Qiao","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154514_bib24","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.7150\/thno.31052","article-title":"LncRNA DCRF regulates cardiomyocyte autophagy by targeting miR-551b-5p in diabetic cardiomyopathy","volume":"9","author":"Feng","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bbrc.2026.154514_bib25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00011-021-01500-y","article-title":"NORAD lentivirus shRNA mitigates fibrosis and inflammatory responses in diabetic cardiomyopathy via the ceRNA network of NORAD\/miR-125a-3p\/Fyn","volume":"70","author":"Liu","year":"2021","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bbrc.2026.154514_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fcell.2020.00243","article-title":"LncRNA-MIAT-mediated miR-214-3p silencing is responsible for IL-17 production and cardiac fibrosis in diabetic cardiomyopathy","volume":"8","author":"Qi","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2026.154514_bib27","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s11427-021-1982-8","article-title":"LncDACH1 promotes mitochondrial oxidative stress of cardiomyocytes by interacting with sirtuin3 and aggravates diabetic cardiomyopathy","volume":"65","author":"Zhang","year":"2022","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.bbrc.2026.154514_bib28","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1002\/jcp.27296","article-title":"LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR\u201034a in diabetic cardiomyopathy","volume":"234","author":"Gao","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbrc.2026.154514_bib29","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/jcmm.17835","article-title":"MALAT1\/miR-185-5p mediated high glucose-induced oxidative stress, mitochondrial injury and cardiomyocyte apoptosis via the RhoA\/ROCK pathway","volume":"27","author":"Wang","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2026.154514_bib30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijcard.2015.10.136","article-title":"Down-regulation of lncRNA MALAT1 reduces cardiomyocyte apoptosis and improves left ventricular function in diabetic rats","volume":"203","author":"Zhang","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154514_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.142191","article-title":"MALAT1-mediated recruitment of the histone methyltransferase EZH2 to the microRNA-22 promoter leads to cardiomyocyte apoptosis in diabetic cardiomyopathy","volume":"766","author":"Wang","year":"2021","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.bbrc.2026.154514_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41419-021-04484-z","article-title":"METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA","volume":"13","author":"Meng","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.154514_bib33","doi-asserted-by":"crossref","first-page":"9995","DOI":"10.1111\/jcmm.16890","article-title":"Inhibition of the long non-coding RNA ZFAS1 attenuates ferroptosis by sponging miR-150-5p and activates CCND2 against diabetic cardiomyopathy","volume":"25","author":"Ni","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2026.154514_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41392-022-01306-2","article-title":"CircRNA DICAR as a novel endogenous regulator for diabetic cardiomyopathy and diabetic pyroptosis of cardiomyocytes","volume":"8","author":"Yuan","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.154514_bib35","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.omtn.2019.06.026","article-title":"A novel circular RNA mediates pyroptosis of diabetic cardiomyopathy by functioning as a competing endogenous RNA","volume":"17","author":"Yang","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbrc.2026.154514_bib36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bbrc.2017.04.044","article-title":"A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-beta1","volume":"487","author":"Zhou","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154514_bib37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijcard.2019.04.006","article-title":"Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p","volume":"292","author":"Ni","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154514_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174915","article-title":"CircRNA CDR1as promotes cardiomyocyte apoptosis through activating hippo signaling pathway in diabetic cardiomyopathy","volume":"922","author":"Shao","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154514_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.13471","article-title":"CircMAP3K5 promotes cardiomyocyte apoptosis in diabetic cardiomyopathy by regulating miR-22-3p\/DAPK2 Axis","volume":"16","author":"Shen","year":"2024","journal-title":"J. Diabetes"},{"key":"10.1016\/j.bbrc.2026.154514_bib40","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1080\/21655979.2021.2024688","article-title":"CircularRNA circ_0071269 knockdown protects against from diabetic cardiomyopathy injury by microRNA-145\/gasdermin A axis","volume":"13","author":"Fu","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.bbrc.2026.154514_bib41","article-title":"Vildagliptin attenuates myocardial dysfunction and restores autophagy via miR-21\/SPRY1\/ERK in diabetic mice heart","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154514_bib42","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1096\/fj.201902692R","article-title":"Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1\/miR-141-mediated NLRP3 inflammasome and TGF-beta1\/Smads signaling in diabetic cardiomyopathy","volume":"34","author":"Che","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2026.154514_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2023.5252","article-title":"Berberine blocks inflammasome activation and alleviates diabetic cardiomyopathy via the miR-18a-3p\/Gsdmd pathway","volume":"51","author":"Yang","year":"2023","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbrc.2026.154514_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.806966","article-title":"Ranolazine inhibits pyroptosis via regulation of miR-135b in the treatment of diabetic cardiac fibrosis","volume":"9","author":"Ren","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbrc.2026.154514_bib45","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1111\/jcmm.14510","article-title":"Non-coding RNA involvement in the pathogenesis of diabetic cardiomyopathy","volume":"23","author":"Zhang","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2026.154514_bib46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/dmrr.1054","article-title":"miR133a regulates cardiomyocyte hypertrophy in diabetes","volume":"26","author":"Feng","year":"2010","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.bbrc.2026.154514_bib47","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00125-020-05353-8","article-title":"Involvement of circHIPK3 in the pathogenesis of diabetic cardiomyopathy in mice","volume":"64","author":"Wang","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2026.154514_bib48","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis","volume":"105","author":"van Rooij","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154514_bib49","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154514_bib50","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.3390\/cells11193117","article-title":"In vivo inhibition of miR-34a modestly limits cardiac enlargement and fibrosis in a mouse model with established type 1 diabetes-induced cardiomyopathy, but does not improve diastolic function","volume":"11","author":"Bernardo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.154514_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175732","article-title":"LncRNA DANCR deficiency promotes high glucose-induced endothelial to mesenchymal transition in cardiac microvascular cells via the FoxO1\/DDAH1\/ADMA signaling pathway","volume":"950","author":"Wu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154514_bib52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11892-025-01590-6","article-title":"From type 2 diabetes mellitus to diabetic cardiomyopathy - a systematic review on the role of MicroRNA","volume":"25","author":"Zarek-Starzewska","year":"2025","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.bbrc.2026.154514_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.709123","article-title":"MicroRNA-195-5p downregulation inhibits endothelial mesenchymal transition and myocardial fibrosis in diabetic cardiomyopathy by targeting Smad7 and inhibiting transforming growth factor beta 1-Smads-Snail pathway","volume":"12","author":"Ding","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrc.2026.154514_bib54","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","article-title":"Metabolic remodelling in heart failure","volume":"15","author":"Bertero","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154514_bib55","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCRESAHA.118.314177","article-title":"Genomic reorganization of lamin-associated domains in cardiac myocytes is associated with differential gene expression and DNA methylation in human dilated cardiomyopathy","volume":"124","author":"Cheedipudi","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2026.154514_bib56","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6143129","article-title":"Subclinical detection of diabetic cardiomyopathy with MicroRNAs: challenges and perspectives","volume":"2016","author":"Leon","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.bbrc.2026.154514_bib57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41598-017-00070-6","article-title":"Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes","volume":"7","author":"de Gonzalo-Calvo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154514_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13875-2","article-title":"Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy","volume":"7","author":"Copier","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154514_bib59","first-page":"167","article-title":"Diabetes and associated cardiovascular complications: the role of microRNAs","volume":"8","author":"Macvanin","year":"2023","journal-title":"Cardiology"},{"key":"10.1016\/j.bbrc.2026.154514_bib60","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41467-017-01737-4","article-title":"Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling","volume":"8","author":"Sassi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154514_bib61","first-page":"4817","article-title":"LncRNA HOTAIR improves diabetic cardiomyopathy by increasing viability of cardiomyocytes through activation of the PI3K\/Akt pathway","volume":"16","author":"Qi","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbrc.2026.154514_bib62","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1038\/s41598-021-82345-7","article-title":"Identification and analysis of circulating long non-coding RNAs with high significance in diabetic cardiomyopathy","volume":"11","author":"Pant","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154514_bib63","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1080\/21655979.2022.2031395","article-title":"Circular RNA circHIPK3 is downregulated in diabetic cardiomyopathy and overexpression of circHIPK3 suppresses PTEN to protect cardiomyocytes from high glucose-induced cell apoptosis","volume":"13","author":"Jiang","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.bbrc.2026.154514_bib64","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.omtn.2019.02.004","article-title":"Circulating long non-coding RNA ENST00000507296 is a prognostic indicator in patients with dilated cardiomyopathy","volume":"16","author":"Zhang","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbrc.2026.154514_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.110944","article-title":"Value of circulating miRNA-21 in the diagnosis of subclinical diabetic cardiomyopathy","volume":"518","author":"Tao","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154514_bib66","article-title":"CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts","volume":"7","author":"Tang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154514_bib67","first-page":"47","article-title":"Targeting miRNA for therapy of juvenile and adult diabetic cardiomyopathy, Exosomes","author":"Nandi","year":"2018","journal-title":"Stem Cells and MicroRNA: Aging"},{"key":"10.1016\/j.bbrc.2026.154514_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1124613","article-title":"Diabetic cardiomyopathy: the role of microRNAs and long non-coding RNAs","volume":"14","author":"Macvanin","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154514_bib69","article-title":"Current status and potential therapeutic strategies for using non-coding RNA to treat diabetic cardiomyopathy","volume":"11","author":"Rai","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrc.2026.154514_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.665811","article-title":"Emerging role of long non-coding RNAs in diabetic vascular complications","volume":"12","author":"Tanwar","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154514_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2023.13081","article-title":"Perspectives of circular RNAs in diabetic complications from biological markers to potential therapeutic targets","volume":"28","author":"Yuan","year":"2023","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2026.154514_bib72","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1093\/eurheartj\/ehx165","article-title":"Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives","volume":"39","author":"Poller","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2026.154514_bib73","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","article-title":"Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study","volume":"42","author":"Taubel","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2026.154514_bib74","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1111\/jcmm.14509","article-title":"Mechanical stress alters protein O-GlcNAc in human periodontal ligament cells","volume":"23","author":"Frank","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2026.154514_bib75","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1093\/eurheartj\/ehv713","article-title":"A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223","volume":"37","author":"Wang","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2026.154514_bib76","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41569-019-0218-x","article-title":"RNA-based diagnostic and therapeutic strategies for cardiovascular disease","volume":"16","author":"Lu","year":"2019","journal-title":"Nat. Rev. Cardiol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26012787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26012787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:35:06Z","timestamp":1788950106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26012787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":76,"alternative-id":["S0006291X26012787"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154514","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNAs in diabetic cardiomyopathy: Mechanistic insights, diagnostic and prognostic potential, and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154514"}}